Guogui Sun

North China University of Science and Technology — China

Biochemistry, Genetics and Molecular Biology · Life Sciences

24h-index2.1kcitations108works2.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA modifications and cancer(33), Lung Cancer Research Studies(28), Epigenetics and DNA Methylation(21), MicroRNA in disease regulation(19), Cancer-related molecular mechanisms research(15)

Publications108 total

Farrerol inhibits proliferation and migration of colorectal cancer via the VEGF signaling pathway: evidence from network pharmacology, molecular docking, molecular dynamics simulation, and in vitro experiments
Frontiers in Pharmacology·2025Open Access
Treatment of primary pulmonary adenoid cystic carcinoma using concurrent chemoradiotherapy combined with imatinib ：A case report
2025Open Access
Research progress and potential of organoids based on biomimetic hydrogel materials
Colloids and Surfaces B Biointerfaces·2025· 1 cited
Characterization of the extrinsic and intrinsic signatures and therapeutic vulnerability of small cell lung cancers
Signal Transduction and Targeted Therapy·2025· 3 citedOpen Access
The burden trend and projection of tracheal, bronchial, and lung cancer attributable to air pollution: Based on the global burden of disease study 2021
Next research.·2025· 1 cited
SIRT4 Promotes Pancreatic Cancer Stemness by Enhancing Histone Lactylation and Epigenetic Reprogramming Stimulated by Calcium Signaling
Advanced Science·2025· 9 citedOpen Access
SIRT4 Controls Acetyl-CoA Synthesis to Promote Stemness and Invasiveness of Hepatocellular Carcinoma through Deacetylating MCCC2
International Journal of Biological Sciences·2025· 1 citedOpen Access
Mechanism of action for Troxerutin targeting the sialylation-related gene EGLN3 for the treatment of LUAD
Scientific Reports·2025Open Access
Comparative Mortality in Adrenal Insufficiency Patients
Journal of Insurance Medicine·2025
Toripalimab plus chemotherapy for first line treatment of advanced non-small cell lung cancer (CHOICE-01): final OS and biomarker exploration of a randomized, double-blind, phase 3 trial
Signal Transduction and Targeted Therapy·2024· 10 citedOpen Access
A plain language summary of results from the CHOICE-01 trial of toripalimab plus chemotherapy for advanced non-small cell lung cancer (NSCLC)
Future Oncology·2024Open Access
Integrated machine learning to predict the prognosis of lung adenocarcinoma patients based on <scp>SARS</scp>‐<scp>COV</scp>‐2 and lung adenocarcinoma crosstalk genes
Cancer Science·2024Open Access
[Isoliquiritigenin Modulates the Effect of LINC01503 
on Lung Squamous Carcinoma Cells].
PubMed·2024· 1 citedOpen Access
Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study
EClinicalMedicine·2024· 7 citedOpen Access
Development and Validation of the Oxidative Stress Related lncRNAs for Prognosis in Esophageal Squamous Cell Carcinoma
Cancers·2023· 3 citedOpen Access
Efficacy of radiomics model based on the concept of gross tumor volume and clinical target volume in predicting occult lymph node metastasis in non-small cell lung cancer
Frontiers in Oncology·2023· 7 citedOpen Access
Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study
BMC Medicine·2023· 29 citedOpen Access
The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development
Journal for ImmunoTherapy of Cancer·2023· 73 citedOpen Access
Supplementary Figure Legend from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer
2023Open Access
Supplementary Table 3 from DNA Methylation-Mediated Repression of miR-886-3p Predicts Poor Outcome of Human Small Cell Lung Cancer
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Wanning Hu(15), Meiyue Liu(11), Yi Niu(8), Peng Gao(8), Yadi Wang(8), Jie Zhang(6), Yang Zhao(6), Xiaomei Wei(5), Wei Zhou(5), Buhai Wang(4), Xiuwen Wang(4), Yongmei Song(4), Hongmin Li(4), Yifang Lu(4), Jiarui Yu(4), Yue Zhao(4), Yunjie Cheng(4), Congrong Yang(4), Yongqian Shu(3), Nan Bi(3)